BD 328431 - Syringe 0.3 cc 30 Gauge x 1/2 Inch U-100 Ultra-Fine Insulin with Needle 100/BX, 5 BX/CA
The BD 328431 Ultra-Fine Insulin Syringe 0.3 cc 30G x 1/2 Inch is a precision-engineered insulin delivery device designed to support accurate dosing and enhanced patient comfort. Manufactured by Becton, Dickinson and Company, this syringe-and-needle combination is calibrated specifically for U-100 insulin and is intended for patients who require small, precise insulin doses.
The ultra-fine 30-gauge needle and short 1/2 inch length are designed to reduce injection discomfort while maintaining reliable insulin delivery. The integrated needle eliminates assembly steps, supporting safe, efficient use in both clinical and home-care environments.
Key Benefits
The 0.3 cc barrel allows for precise measurement of small insulin doses, making it ideal for pediatric patients, insulin-sensitive individuals, and those requiring fine dose adjustments. The ultra-fine 30-gauge needle helps minimize injection pain and tissue trauma, supporting improved patient adherence.
Clear, easy-to-read unit markings enhance dosing accuracy, while the smooth plunger action provides controlled insulin delivery. The sterile, single-use design supports infection prevention and consistent performance.
Compatibility and Applications
The BD 328431 syringe is specifically designed for use with U-100 insulin formulations. It is not intended for use with other insulin concentrations.
Common applications include routine insulin administration for diabetes management in hospitals, outpatient clinics, long-term care facilities, and home healthcare settings. The syringe is suitable for both professional use and patient self-administration when prescribed and instructed by a healthcare provider.
Usage Guidelines
The syringe should be removed from its sterile packaging immediately before use. Insulin should be drawn according to prescribed dosage using standard aseptic technique. Injection should be performed following recommended subcutaneous injection guidelines.
After use, the syringe must be disposed of immediately in an approved sharps container. The product is intended for single use only and should never be reused.
Certifications, Safety Standards, and Regulatory Approvals
The BD 328431 Ultra-Fine Insulin Syringe is manufactured under quality management systems aligned with FDA medical device regulations and internationally recognized manufacturing standards. These controls ensure accurate calibration, sterility, and consistent needle performance.
Regulatory compliance confirms the products suitability for use in regulated healthcare environments and for prescribed patient use in the United States.
Comparison with Competitor Products
Compared with standard insulin syringes, the BD Ultra-Fine design offers enhanced patient comfort through its thinner needle and smooth injection performance. While some competitor syringes provide similar unit capacity, BD syringes are widely trusted for their consistent unit markings, reliable needle sharpness, and manufacturing quality.
Patients and clinicians often prefer BD insulin syringes due to their dosing precision, comfort-focused design, and long-standing clinical reputation.
Typical User Profile and Application Scenarios
Typical users include patients managing diabetes, nurses, physicians, endocrinology specialists, and trained caregivers. The syringe is especially effective for individuals requiring low-dose insulin administration with high accuracy.
It is commonly used in hospitals, outpatient diabetes clinics, long-term care facilities, and home-care environments.
Best Practices for Use and Maintenance
Best practice includes verifying insulin concentration compatibility before use and confirming the correct dose prior to injection. The syringe should remain sealed until use and handled only by trained individuals or instructed patients.
Immediate disposal after injection supports sharps safety and infection control practices. As a single-use device, no cleaning or maintenance is required.
Regulatory and Safety Information
The BD 328431 Syringe is classified as a regulated medical device and complies with applicable FDA requirements for insulin delivery devices. Its design supports compliance with diabetes care standards and sharps safety guidelines.
Following healthcare provider instructions and institutional policies ensures safe and effective insulin administration.
How to Order
The BD 328431 Syringe 0.3 cc 30 Gauge x 1/2 Inch U-100 Ultra-Fine Insulin with Needle is available through the CIA Medical website. Add the product to your cart and proceed through the secure checkout process.
For bulk purchasing, institutional pricing, or product assistance, contact CIA Medical customer service at 312 275 5850 or use the contact form available on this page for prompt support.
